Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 9 (Sep 2000)

Issues

Polymorphisms in UDP Glucuronosyltransferase Genes: Functional Consequences and Clinical Relevance

Peter I. Mackenzie / John O. Miners / Ross A. McKinnon
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.129

Abstract

As glucuronidation is a major process for the metabolism and removal of lipophilic chemicals, polymorphic variations in genes encoding the enzymes involved in this process, the UDP glucuronosyltransferases (UGT), may have a significant impact on our capacity to detoxify and eliminate drugs and toxins. Although 24 human UGT genes have been identified to date, only polymorphisms in five UGTs, viz. UGT1A1, UGT1A6, UGT2B4, UGT2B7 and UGT2B15 have been described. Polymorphisms in UGT1A1, the major bilirubin-glucuronidating form, often result in a decreased capacity to glucuronidate bilirubin, such as observed in Gilbert Syndrome and some forms of perinatal jaundice. The frequencies of individual UGT1A1 polymorphisms show extensive variability across ethnic groups. Two variants of UGT1A6 and UGT2B4 and one variant of UGT2B7 and UGT2B15 have been identified. However, the clinical significance of these variants is unclear. More UGT polymorphisms will undoubtedly be discovered when the human genome is sequenced. However, unless the UGT in question is responsible for the exclusive metabolism of a particular drug or chemical (e.g. UGT1A1 and bilirubin) or is the predominant or only UGT present in the cell, it is unlikely that these polymorphisms will be of major clinical significance.

About the article

Published Online: 2005-06-01

Published in Print: 2000-09-18


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.129.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
F Skorpen, EA Laugsand, P Klepstad, and S Kaasa
Palliative Medicine, 2008, Volume 22, Number 4, Page 310
[2]
Shujuan Chen, Deirdre Beaton, Nghia Nguyen, Kathy Senekeo-Effenberger, Erin Brace-Sinnokrak, Upendra Argikar, Rory P. Remmel, Jocelyn Trottier, Olivier Barbier, Joseph K. Ritter, and Robert H. Tukey
Journal of Biological Chemistry, 2005, Volume 280, Number 45, Page 37547
[3]
Daniela Ennulat, Dana Walker, Frances Clemo, Michal Magid-Slav, David Ledieu, Mark Graham, Suzanne Botts, and Laura Boone
Toxicologic Pathology, 2010, Volume 38, Number 5, Page 810
[4]
Ashish S. Chiddarwar, Selma Z. D'Silva, Roshan B. Colah, Kanjaksha Ghosh, and Malay B. Mukherjee
Annals of Human Genetics, 2017, Volume 81, Number 1, Page 11
[5]
Ross A McKinnon and Michael B Ward
Journal of Pharmacy Practice and Research, 2003, Volume 33, Number 2, Page 133
[6]
U. A. Argikar, K. Senekeo-Effenberger, E. E. Larson, R. H. Tukey, and R. P. Remmel
Xenobiotica, 2009, Volume 39, Number 11, Page 826
[7]
Dong Gui Hu, Peter I. Mackenzie, Ross A. McKinnon, and Robyn Meech
Drug Metabolism Reviews, 2016, Volume 48, Number 1, Page 47
[8]
Shufeng Zhou, Eli Chan, Wei Duan, Min Huang, and Yu-Zong Chen
Drug Metabolism Reviews, 2005, Volume 37, Number 1, Page 41
[9]
Balram Chowbay, Shufeng Zhou, and Edmund J. D. Lee
Drug Metabolism Reviews, 2005, Volume 37, Number 2, Page 327
[10]
Michael B. Fisher, Mary F. Paine, Timothy J. Strelevitz, and Steven A. Wrighton
Drug Metabolism Reviews, 2001, Volume 33, Number 3-4, Page 273
[14]
Hee Jung Shin, Jason Yongha Kim, Hyun Sub Cheong, Han Sung Na, Hyoung Doo Shin, and Myeon Woo Chung
Therapeutic Drug Monitoring, 2015, Volume 37, Number 3, Page 369
[15]
J. C. Martin-Escudero, A. Duenas-Laita, J. L. Perez-Castrillon, and V. Herreros-Fernandez
The British Journal of Psychiatry, 2003, Volume 182, Number 3, Page 267
[16]
Andrea Y. Angstadt, Terryl J. Hartman, Samuel M. Lesko, Joshua E. Muscat, Junjia Zhu, Carla J. Gallagher, and Philip Lazarus
Genes, Chromosomes and Cancer, 2014, Volume 53, Number 6, Page 454
[17]
Michelle A. Rudek, Jürgen Venitz, Yuichi Ando, Eddie Reed, James M. Pluda, and William D. Figg
The Journal of Clinical Pharmacology, 2003, Volume 43, Number 10, Page 1124
[18]
Andrew Rowland, John O. Miners, and Peter I. Mackenzie
The International Journal of Biochemistry & Cell Biology, 2013, Volume 45, Number 6, Page 1121
[19]
Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, and Steven A. Wrighton
The Journal of Clinical Pharmacology, 2003, Volume 43, Number 5, Page 443
[20]
Viet Hong Phan, Melissa M Moore, Andrew J McLachlan, Micheline Piquette-Miller, Hongmei Xu, and Stephen J Clarke
Expert Opinion on Drug Metabolism & Toxicology, 2009, Volume 5, Number 3, Page 243
[21]
Selma D'Silva, Roshan B. Colah, Kanjaksha Ghosh, and Malay B. Mukherjee
Gene, 2013, Volume 513, Number 1, Page 36
[22]
Lucia Politi, Fabio Leone, Luca Morini, and Aldo Polettini
Analytical Biochemistry, 2007, Volume 368, Number 1, Page 1
[23]
Stephen George and Michael Leaver
Marine Environmental Research, 2002, Volume 54, Number 3-5, Page 259
[24]
S.J. de Visser, N. Uchida, E. van Vliet-Daskalopoulou, I. Fukazawa, M.B.A. van Doorn, M.W. van den Heuvel, C.S.M. Machielsen, E. Uchida, and A.F. Cohen
Contraception, 2003, Volume 68, Number 3, Page 195
[25]
M Pirmohamed and D J Back
The Pharmacogenomics Journal, 2001, Volume 1, Number 4, Page 243
[26]
Athena Starlard-Davenport, Beverly Lyn-Cook, and Anna Radominska-Pandya
Steroids, 2008, Volume 73, Number 1, Page 139
[27]
Anthony R Tricker
Toxicology, 2003, Volume 183, Number 1-3, Page 151
[28]
Giuseppe Latini, Claudio De Felice, and Alberto Verrotti
Reproductive Toxicology, 2004, Volume 19, Number 1, Page 27
[30]
Michael A. Malfatti, Rebekah W. Wu, and James S. Felton
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2005, Volume 570, Number 2, Page 205
[31]
Giampietro Gasparini, Raffaele Longo, Francesco Torino, Domenico Gattuso, Alessandro Morabito, and Giuseppe Toffoli
Critical Reviews in Oncology/Hematology, 2006, Volume 57, Number 1, Page 79
[32]
Munir Pirmohamed and B.Kevin Park
Trends in Pharmacological Sciences, 2001, Volume 22, Number 6, Page 298
[33]
Gérard Siest, Luc Ferrari, Marie-José Accaoui, Anne-Marie Batt, and Sophie Visvikis
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 4
[34]
Ursula Ehmer, Arndt Vogel, Jan Karl Schütte, Britta Krone, Michael P. Manns, and Christian P. Strassburg
Hepatology, 2004, Volume 39, Number 4, Page 970
[35]
B. P. Sweeney and M. Grayling
Anaesthesia, 2009, Volume 64, Number 2, Page 179
[36]
Friedrich Martin Wurst, Gregory E. Skipper, and Wolfgang Weinmann
Addiction, 2003, Volume 98, Page 51
[37]
Marta Boffito, Alan Winston, and Andrew Owen
Current Opinion in Infectious Diseases, 2005, Volume 18, Number 6, Page 543
[38]
Giampietro Gasparini, Raffaele Longo, Francesco Torino, Carlo Barone, and Giuseppe Toffoli
The Cancer Journal, 2005, Volume 11, Number 3, Page 175
[39]
Ge Sun, Mingyuan Wu, Jiang Cao, and Lizhong Du
Acta Paediatrica, 2007, Volume 96, Number 11, Page 1622
[40]
H. J. M. van Kan, L. H. van den Berg, G. J. Groeneveld, R. J. H. M. van der Straaten, P. W. J. van Vught, L. Lie-A-Huen, and H.-J. Guchelaar
Biopharmaceutics & Drug Disposition, 2008, Volume 29, Number 3, Page 139
[41]
Esther F. A. Brandon, Rolf W. Sparidans, Ronald D. van Ooijen, Irma Meijerman, Luis Lopez Lazaro, Ignacio Manzanares, Jos H. Beijnen, and Jan H. M. Schellens
Investigational New Drugs, 2007, Volume 25, Number 1, Page 9
[42]
Esther F. A. Brandon, Rolf W. Sparidans, Kees-Jan Guijt, Sjoerd Löwenthal, Irma Meijerman, Jos H. Beijnen, and Jan H. M. Schellens
Investigational New Drugs, 2006, Volume 24, Number 1, Page 3
[43]
B. P. Sweeney and J. Bromilow
Anaesthesia, 2006, Volume 61, Number 2, Page 159
[44]
Shinji Tatami, Akiko Sarashina, Norio Yamamura, Takashi Igarashi, and Yusuke Tanigawara
Drug Metabolism and Pharmacokinetics, 2003, Volume 18, Number 3, Page 203
[45]
J. A. J. H. Critchley, L. A. H. Critchley, P. J. Anderson, and B. Tomlinson
Journal of Clinical Pharmacy and Therapeutics, 2005, Volume 30, Number 2, Page 179
[46]
Dario Cattaneo, Norberto Perico, and Giuseppe Remuzzi
American Journal of Transplantation, 2004, Volume 4, Number 3, Page 299

Comments (0)

Please log in or register to comment.
Log in